Advanced Projects Group and Cellectricon collaborate to produce the Dynaflow HT patch clamp equipment system

The Automation Partnership (TAP), a world leading supplier of innovative automation for life science applications today announced its Advanced Projects Group, has successfully collaborated with Cellectricon, the Swedish provider of innovative screening solutions for drug discovery, to produce fully automated high throughput patch clamp equipment known as the Dynaflow^®HT System.

Patch clamping is the gold standard for screening ion channels in drug discovery. Currently, few commercial instruments exist for high throughput primary and secondary screening so TAP’s Advanced Projects Group of specialist engineers, software designers and biologists have worked closely with Cellectricon to produce the Dynaflow^®HT System to meet this need. The Dynaflow^®HT System, which has been developed in collaboration with AstraZeneca in Sweden is now becoming commercially available and addresses the limits of existing ion channel screening equipment by combining high levels of automated throughput with accurate and affordable data measurement.

Jonas Ohlsson, CEO of Cellectricon explained: “We approached TAP’s Advanced Projects Group because TAP has an unrivalled reputation in the pharma industry for delivering premier automation to improve productivity in cell culture and drug discovery. TAP’s Advanced Projects Group are also accustomed to partnering with all the major pharma companies to ensure projects are carried out to their stringent quality specifications. Therefore, it made perfect sense to collaborate with them to bring a new generation of high throughput electrophysiology systems to market.”

Nick Cooke, TAP’s COO and Head of the Advanced Projects Group stated: “We are delighted to have had the opportunity to work with such high calibre microfluidics experts at Cellectricon. The introduction of the first Dynaflow^®HT System shows that our Advanced Projects Group understands where automation will enhance cell processing and can rapidly translate this into practical technology.”

Cooke added: “We are now actively seeking other collaborative projects and would welcome enquiries from biotech companies or academic institutes, as well as life science equipment manufacturers that need the Advanced Project Group’s unique brand of expertise to design and develop the best systems to reliably automate their processes.”